ADCX-020

Adcytherix SAS · Phase 1 active Small molecule

At a glance

Generic name	ADCX-020
Sponsor	Adcytherix SAS
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ADCX-020 CI brief — competitive landscape report
ADCX-020 updates RSS · CI watch RSS
Adcytherix SAS portfolio CI